An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.

Area of Science:

• Computational biology
• Pharmacology
• Genomics

Background:

• Drug development is costly and time-consuming.
• Drug repurposing offers a faster, cheaper alternative by exploring existing medications for new diseases.
• Computational methods, particularly in silico approaches, can significantly expedite this process.

Purpose of the Study:

• To present a detailed, step-by-step methodology for a transcriptomics-based computational drug repurposing pipeline.
• To provide a comprehensive guide for identifying potential drug candidates for diseases using gene expression data.
• To streamline the process from data selection to the derivation of a prioritized list of repurposed drugs.

Main Methods:

• Selection and curation of transcriptomics datasets.
• Statistical analysis to identify differentially expressed genes (over- and under-expressed).
• Identifier conversion, in silico drug repurposing analysis, filtering, cross-tool screening, and results validation.

Main Results:

• A robust pipeline for transcriptomics-based drug repurposing is detailed.
• The methodology enables the extraction of key gene identifiers and facilitates drug screening.
• The process leads to a refined list of potential repurposed drugs acting as inhibitors.

Conclusions:

• The presented pipeline offers an efficient computational approach to accelerate drug repurposing.
• Transcriptomics data analysis is a valuable strategy for identifying novel therapeutic applications of existing drugs.
• This methodology aids in reducing the time and cost associated with bringing new treatments to patients.